Claudia Maria Dantas de Maio Carrilho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Claudia Maria Dantas de Maio Carrilho has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Cintia Magalhães Carvalho Grion
Universidade Estadual de Londrina, Brazil
3 shared publications - Lucienne Tibery Queiroz Cardoso
Universidade Estadual de Londrina, Brazil
3 shared publications A.L. Mezzaroba
Intensive Care Division, Hospital Universitário Regional do Norte do Paraná, Universidade Estadual de Londrina, Paraná, Brazil
1 shared publication- Amanda Pinheiro Zago
Universidade Estadual de Londrina - UEL
1 shared publication - Ana Clara Donini Nazima
Universidade Estadual de Londrina - UEL
1 shared publication - Ana Paula Matos Porto
Department of Infectious Diseases and Tropical Medicine, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 68, e31
Clostridioides difficile infections in seven Brazilian hospitals during the COVID-19 pandemic: hand hygiene and antimicrobial consumption
This study aimed to evaluate the incidence density of Clostridioides difficile infections (CDIs), hand hygiene adherence, and antimicrobial consumption across Brazilian hospitals during the COVID-19 pandemic. An ecological study was conducted in seven Brazilian hospitals from June 2018 to December 2019 (pre-pandemic) and from June 2020 to December 2021(pandemic). Data on CDI incidence density, hand hygiene adherence, and antimicrobial consumption were collected. CDI incidence was assessed based on the number of monthly cases and the incidence density rate per 10,000 patient-days. This study involved hospitals from four states and included three public and four private institutions. Statistical analyses were performed using the Mann-Whitney U test in R (p < 0.05). Time series analysis used joinpoint regression to determine monthly percent change, average monthly percent change, and 95% confidence intervals. Although statistically insignificant, an upward trend occurred in CDI incidence (p = 0.081) from the pre-pandemic to the pandemic periods. Consumption of azithromycin (p < 0.01) and levofloxacin (p < 0.01) increased significantly, whereas ceftriaxone use decreased (p = 0.0038). The joinpoint regression analysis of antimicrobial consumption trends during the pandemic showed trend changes for vancomycin and meropenem defined daily dose, with higher consumption during the second wave of COVID-19 in Brazil. Hand hygiene adherence failed to differ significantly but showed a downward trend in 2020 and 2021. The dynamics of the COVID-19 pandemic and changes in protective measures may have influenced CDI incidence and antimicrobial consumption patterns across the study period.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 68, e31
Open AccessClostridioides difficile infections in seven Brazilian hospitals during the COVID-19 pandemic: hand hygiene and antimicrobial consumption
This study aimed to evaluate the incidence density of Clostridioides difficile infections (CDIs), hand hygiene adherence, and antimicrobial consumption across Brazilian hospitals during the COVID-19 pandemic. An ecological study was conducted in seven Brazilian hospitals from June 2018 to December 2019 (pre-pandemic) and from June 2020 to December 2021(pandemic). Data on CDI incidence density, hand hygiene adherence, and antimicrobial consumption were collected. CDI incidence was assessed based on the number of monthly cases and the incidence density rate per 10,000 patient-days. This study involved hospitals from four states and included three public and four private institutions. Statistical analyses were performed using the Mann-Whitney U test in R (p < 0.05). Time series analysis used joinpoint regression to determine monthly percent change, average monthly percent change, and 95% confidence intervals. Although statistically insignificant, an upward trend occurred in CDI incidence (p = 0.081) from the pre-pandemic to the pandemic periods. Consumption of azithromycin (p < 0.01) and levofloxacin (p < 0.01) increased significantly, whereas ceftriaxone use decreased (p = 0.0038). The joinpoint regression analysis of antimicrobial consumption trends during the pandemic showed trend changes for vancomycin and meropenem defined daily dose, with higher consumption during the second wave of COVID-19 in Brazil. Hand hygiene adherence failed to differ significantly but showed a downward trend in 2020 and 2021. The dynamics of the COVID-19 pandemic and changes in protective measures may have influenced CDI incidence and antimicrobial consumption patterns across the study period.
- Open Access
- 28 February 2023
- Published by The Korean Society of Critical Care Medicine in Acute and Critical Care
- Vol. 38 (1) , 68-75
Risk factors for hospital mortality in intensive care unit survivors: a retrospective cohort study
Background: Deaths can occur after a patient has survived treatment for a serious illness in an intensive care unit (ICU). Mortality rates after leaving the ICU can be considered indicators of health care quality. This study aims to describe risk factors and mortality of surviving patients discharged from an ICU in a university hospital.Methods: Retrospective cohort study carried out from January 2017 to December 2018. Data on age, sex, length of hospital stay, diagnosis on admission to the ICU, hospital discharge outcome, presence of infection, and Simplified Acute Physiology Score III (SAPS 3) prognostic score were collected. Infected patients were considered as those being treated for an infection on discharge from the ICU. Patients were divided into survivors and non-survivors on leaving the hospital. The association between the studied variables was performed using the logistic regression model. Results: A total of 1,025 patients who survived hospitalization in the ICU were analyzed, of which 212 (20.7%) died after leaving the ICU. When separating the groups of survivors and non-survivors according to hospital outcome, the median age was higher among non-survivors. Longer hospital stays and higher SAPS 3 score values were observed among non-survivors. In the logistic regression, the variables age, length of hospital stay, SAPS 3, presence of infection, and readmission to the ICU were associated with hospital mortality.Conclusions: Infection on ICU discharge, ICU readmission, age, length of hospital stay, and SAPS 3 score increased risk of death in ICU survivors.
- 28 February 2023
- Published by The Korean Society of Critical Care Medicine in Acute and Critical Care
- Vol. 38 (1) , 68-75
Open AccessRisk factors for hospital mortality in intensive care unit survivors: a retrospective cohort study
Background: Deaths can occur after a patient has survived treatment for a serious illness in an intensive care unit (ICU). Mortality rates after leaving the ICU can be considered indicators of health care quality. This study aims to describe risk factors and mortality of surviving patients discharged from an ICU in a university hospital.Methods: Retrospective cohort study carried out from January 2017 to December 2018. Data on age, sex, length of hospital stay, diagnosis on admission to the ICU, hospital discharge outcome, presence of infection, and Simplified Acute Physiology Score III (SAPS 3) prognostic score were collected. Infected patients were considered as those being treated for an infection on discharge from the ICU. Patients were divided into survivors and non-survivors on leaving the hospital. The association between the studied variables was performed using the logistic regression model. Results: A total of 1,025 patients who survived hospitalization in the ICU were analyzed, of which 212 (20.7%) died after leaving the ICU. When separating the groups of survivors and non-survivors according to hospital outcome, the median age was higher among non-survivors. Longer hospital stays and higher SAPS 3 score values were observed among non-survivors. In the logistic regression, the variables age, length of hospital stay, SAPS 3, presence of infection, and readmission to the ICU were associated with hospital mortality.Conclusions: Infection on ICU discharge, ICU readmission, age, length of hospital stay, and SAPS 3 score increased risk of death in ICU survivors.
- Open Access
- 11 November 2022
- Published by Universidade Estadual de Londrina in Semina: Ciências Biológicas e da Saúde
- Vol. 43 (2) , 243-250
Associação entre nível de priorização na admissão da unidade de terapia intensiva e desfecho hospitalar
Objetivo: Avaliar a associação entre os níveis de priorização para admissão na unidade de terapia intensiva (UTI) e o prognóstico dos pacientes. Material e método: Estudo longitudinal retrospectivo que incluiu adultos internados na UTI de hospital universitário ano de 2020. As variáveis, coletadas nos prontuários e banco de dados eletrônicos do hospital contemplam: identificação, data de entrada no hospital e de admissão na UTI, diagnósticos, antecedentes, data de alta, desfecho, cálculo do Simplified Acute Physiology Score 3 (SAPS 3) e nível de priorização da admissão. Resultados: O estudo avaliou 274 pacientes. As patologias respiratórias totalizaram 41,25% das admissões, sendo COVID-19 o diagnóstico mais frequente (65 casos confirmados e 2 suspeitos). Dentre as comorbidades, destacam-se hipertensão arterial sistêmica (64,32%), diabetes mellitus (25,82%) e tabagismo (18,78%). O SAPS 3 médio foi de 59,29 pontos, representando uma probabilidade de óbito de 39,00%. A respeito dos níveis de priorizações, 174 (63,50%) pacientes foram classificados como prioridade 1 (P1); 94 (34,31%) pacientes como prioridade 2 (P2); e 6 (2,19%) pacientes como prioridade 3 (P3). Comparando os grupos P1 e P2, a probabilidade de óbito foi, respectivamente, 51,95% e 13,75%. E o número de óbitos observado foi de 90 (60,81%) no grupo P1 e 19 no grupo P2 (25,30%; pConclusão: Os pacientes classificados como P1 foram mais frequentes na amostra de estudo. A classificação de prioridades identificou os pacientes mais graves e com maior taxa de mortalidade na primeira categoria, apesar de não haver diferença na idade, comorbidade e fragilidade.
- 11 November 2022
- Published by Universidade Estadual de Londrina in Semina: Ciências Biológicas e da Saúde
- Vol. 43 (2) , 243-250
Open AccessAssociação entre nível de priorização na admissão da unidade de terapia intensiva e desfecho hospitalar
Objetivo: Avaliar a associação entre os níveis de priorização para admissão na unidade de terapia intensiva (UTI) e o prognóstico dos pacientes. Material e método: Estudo longitudinal retrospectivo que incluiu adultos internados na UTI de hospital universitário ano de 2020. As variáveis, coletadas nos prontuários e banco de dados eletrônicos do hospital contemplam: identificação, data de entrada no hospital e de admissão na UTI, diagnósticos, antecedentes, data de alta, desfecho, cálculo do Simplified Acute Physiology Score 3 (SAPS 3) e nível de priorização da admissão. Resultados: O estudo avaliou 274 pacientes. As patologias respiratórias totalizaram 41,25% das admissões, sendo COVID-19 o diagnóstico mais frequente (65 casos confirmados e 2 suspeitos). Dentre as comorbidades, destacam-se hipertensão arterial sistêmica (64,32%), diabetes mellitus (25,82%) e tabagismo (18,78%). O SAPS 3 médio foi de 59,29 pontos, representando uma probabilidade de óbito de 39,00%. A respeito dos níveis de priorizações, 174 (63,50%) pacientes foram classificados como prioridade 1 (P1); 94 (34,31%) pacientes como prioridade 2 (P2); e 6 (2,19%) pacientes como prioridade 3 (P3). Comparando os grupos P1 e P2, a probabilidade de óbito foi, respectivamente, 51,95% e 13,75%. E o número de óbitos observado foi de 90 (60,81%) no grupo P1 e 19 no grupo P2 (25,30%; pConclusão: Os pacientes classificados como P1 foram mais frequentes na amostra de estudo. A classificação de prioridades identificou os pacientes mais graves e com maior taxa de mortalidade na primeira categoria, apesar de não haver diferença na idade, comorbidade e fragilidade.
- 1 October 2021
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 45 (7) , e22-e24
Increase in the incidence of chronic critical disease in a University Hospital over eight years
- 1 October 2021
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 45 (7) , e22-e24
Increase in the incidence of chronic critical disease in a University Hospital over eight years